[{"address1": "Lil-Dagover-Ring 7", "city": "Gr\u00fcnwald", "zip": "82031", "country": "Germany", "phone": "49 89 6 41 86 0", "website": "https://ir.dermapharm.de", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany. The company operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, Herpotherm, and epiivo brands. The company was founded in 1991 and is based in Gr\u00fcnwald, Germany. Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-AG.", "fullTimeEmployees": 3603, "companyOfficers": [{"maxAge": 1, "name": "Dr. Hans-Georg  Feldmeier", "title": "CEO & Chairman of the Management Board", "fiscalYear": 2023, "totalPay": 1175831, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christof  Dreibholz", "age": 55, "title": "CFO, Chief Compliance Officer & Member of Management Board", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 689627, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andreas  Eberhorn", "age": 47, "title": "Chief Marketing Officer & Member of Management Board", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 684039, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Britta  Hamberger", "title": "Head of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 6, "overallRisk": 10, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "open": 42.684, "dayLow": 42.684, "dayHigh": 42.684, "regularMarketOpen": 42.684, "regularMarketDayLow": 42.684, "regularMarketDayHigh": 42.684, "exDividendDate": 1719532800, "beta": 1.107, "trailingPE": 12.300864, "volume": 476, "regularMarketVolume": 476, "bid": 35.69, "ask": 40.69, "marketCap": 2298106368, "fiftyTwoWeekLow": 42.68399, "fiftyTwoWeekHigh": 42.684, "priceToSalesTrailing12Months": 2.004113, "fiftyDayAverage": 42.68399, "twoHundredDayAverage": 42.68399, "trailingAnnualDividendRate": 0.88, "trailingAnnualDividendYield": "Infinity", "currency": "USD", "enterpriseValue": 3220843264, "profitMargins": 0.07241, "floatShares": 17429888, "sharesOutstanding": 53840000, "heldPercentInsiders": 0.6774, "heldPercentInstitutions": 0.16973, "bookValue": 10.221, "priceToBook": 4.176108, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": 83037000, "trailingEps": 3.47, "enterpriseToRevenue": 2.809, "enterpriseToEbitda": 14.802, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "DMPHF", "underlyingSymbol": "DMPHF", "shortName": "DERMAPHARM HLDG SE", "longName": "Dermapharm Holding SE", "firstTradeDateEpochUtc": 1669732200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "446bebb2-6d78-3dc1-b224-bca77043778a", "gmtOffSetMilliseconds": -14400000, "currentPrice": 42.684, "recommendationKey": "none", "totalCash": 165762000, "totalCashPerShare": 3.072, "ebitda": 217592000, "totalDebt": 1078396032, "quickRatio": 0.635, "currentRatio": 1.581, "totalRevenue": 1146695040, "debtToEquity": 193.806, "revenuePerShare": 21.247, "returnOnAssets": 0.05708, "returnOnEquity": 0.15, "freeCashflow": 155186752, "operatingCashflow": 187310000, "revenueGrowth": 0.065, "grossMargins": 0.62176, "ebitdaMargins": 0.18976, "operatingMargins": 0.10026, "financialCurrency": "EUR", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]